Pharmaceutical Commerce - February 2025

Click the title above for a link to open the Pharmaceutical Commerce February 2025 issue in an interactive PDF format.

Our February issue is highlighted by an examination of the latest trends and strategies from the perspective of third-party logistics providers, and introduces new expert commentary covering a pair of pivotal realms in the pharma supply chain journey.

Digging a little deeper into the drug class phenomenon reveals some interesting takeaways on a smaller subgroup of users.

Trade & Channel Strategies conference explores the frontline issues related to strategy, distribution, and reimbursement—while digging into creative solutions to solve them.

Leaders with top third-party logistics providers discuss the evolving landscape for the sector in 2025—and the new strides made in their quest to help transform the pharma supply chain.

How chain and local closures are impacting healthcare access.

From matrix programs to anti-abandonment strategies, predictions for a new era.

What factors should be considered—and how can both parties benefit long-term?

Introducing a new Pharma Commerce column focused on combating illicit trade and protecting product integrity—and ultimately patients.

Finding the optimal balance in pharmacy benefit manager reform.

New engagement approaches can help drive treatment gains in underrepresented communities.

A look at the actionable steps needed to elicit change.

One packaging aspect—the tape—is often overlooked, but is a valuable component of the shipping process.